La maladie de Parkinson en France (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Mort cellulaire And NotChiyoko Minami

List of bibliographic references

Number of relevant bibliographic references: 64.
Ident.Authors (with country if any)Title
000196 Nicolas Aznavour [France] ; Christophe Cendres-Bozzi [France] ; Laetitia Lemoine [France] ; Colette Buda [France] ; Jean-Pierre Sastre [France] ; Zoïa Mincheva [France] ; Luc Zimmer [France] ; Jian-Sheng Lin [France]MPTP Animal Model of Parkinsonism: Dopamine Cell Death or Only Tyrosine Hydroxylase Impairment? - A Study Using PET Imaging, Autoradiography, and Immunohistochemistry in the Cat
000209 Faraj Terro [France] ; Amandine Magnaudeix [France] ; Marion Crochetet [France] ; Ludovic Martin [France] ; Sylvie Bourthoumieu [France] ; Cornelia-M. Wilson [France] ; Catherine Yardin [France] ; Philippe Leveque [France]GSM-900 MHz at low dose temperature-dependently downregulates α-synuclein in cultured cerebral cells independently of chaperone-mediated-autophagy
000231 Dickon M. Humphrey [Royaume-Uni] ; Richard B. Parsons [Royaume-Uni] ; Zoe N. Ludlow [Royaume-Uni] ; Thomas Riemensperger [France] ; Giovanni Esposito [Belgique] ; Patrik Verstreken [Belgique] ; Howard T. Jacobs [Finlande] ; Serge Birman [France] ; Frank Hirth [Royaume-Uni]Alternative oxidase rescues mitochondria-mediated dopaminergic cell loss in Drosophila
000232 Sophie Schumm [France] ; Claude Sebban [France] ; Charles Cohen-Salmon [France] ; Jacques Callebert [France] ; Jean-Marie Launay [France] ; Jean-Louis Golmard [France] ; Lydie Boussicault [France] ; Isabelle Petropoulos [France] ; Audrey Hild [France] ; Estelle Rousselet [France] ; Annick Prigent [France] ; Bertrand Friguet [France] ; Jean Mariani [France] ; Etienne C. Hirsch [France]Aging of the dopaminergic system and motor behavior in mice intoxicated with the parkinsonian toxin 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine
000282 R. Bordet [France]Bases pharmacologiques des effets disease modifier dans la maladie de Parkinson : MALADIE DE PARKINSON : PEUT-ON EN MODIFIER LE COURS EVOLUTIF ?
000522 Sandrine Greffard [France] ; Marc Verny [France] ; Anne-Marie Bonnet [France] ; Danielle Seilhean [France] ; Jean-Jacques Hauw [France] ; Charles Duyckaerts [France]A stable proportion of Lewy body bearing neurons in the substantia nigra suggests a model in which the Lewy body causes neuronal death
000570 Serena Santucci [France] ; Nicole Zsiirger [France] ; Joëlle Chabry [France]β-N-methylamino-L-alanine induced in vivo retinal cell death
000680 Pierre Cesaro [France]Neuroprotection et maladie de Parkinson
000742 Daniel Alvarez-Fischer [France] ; Serge Guerreiro [France] ; Stephane Hunot [France] ; Francoise Saurini [France] ; Marc Marien [France] ; Pierre Sokoloff [France] ; Etienne C. Hirsch [France] ; Andreas Hartmann [France] ; Patrick P. Michel [France]Modelling Parkinson-like neurodegeneration via osmotic minipump delivery of MPTP and probenecid
000745 Carine Chassain [France] ; Guy Bielicki [France] ; Elodie Durand [France] ; Stéphane Lolignier [France] ; Fatma Essafi [Tunisie] ; Amidou Traore [France] ; Franck Durif [France]Metabolic changes detected by proton magnetic resonance spectroscopy in vivo and in vitro in a murin model of Parkinson's disease, the MPTP-intoxicated mouse
000748 Charlotte Laloux [France] ; Philippe Derambure [France] ; Alexandre Kreisler [France] ; Elise Houdayer [France] ; Servane Brueziere [France] ; Régis Bordet [France] ; Alain Destée [France] ; Christelle Monaca [France]MPTP-treated mice : long-lasting loss of nigral TH-ir neurons but not paradoxical sleep alterations
000867 Duong P. Huynh [États-Unis] ; Dung T. Nguyen [États-Unis] ; Johannes B. Pulst-Korenberg [États-Unis] ; Alexis Brice [France] ; Stefan-M. Pulst [États-Unis]Parkin is an E3 ubiquitin-ligase for normal and mutant ataxin-2 and prevents ataxin-2-induced cell death
000960 P. Rustin [France]Ataxie de Friedreich : dix ans de recherches
000A11 Yuri Bozzi [Italie] ; Emiliana Borrelli [France]Dopamine in neurotoxicity and neuroprotection : what do D2 receptors have to do with it?
000A29 Dale E. Bredesen [États-Unis] ; Rammohan V. Rao [États-Unis] ; Patrick Mehlen [États-Unis, France]Cell death in the nervous system : Neurodegeneration
000A88 Giinter U. Höglinger [France, Allemagne] ; Annie Lannuzel [France] ; Myriam Escobar Khondiker [France, Allemagne] ; Patrick P. Michel [France] ; Charles Duyckaerts [France] ; Jean Feger [France] ; Pierre Champy [France] ; Annick Prigent [France] ; Fadia Medja [France] ; Anne Lombes [France] ; Wolfgang H. Oertel [Allemagne] ; Merle Ruberg [France] ; Etienne C. Hirsch [France]The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy
000B01 Carmen Henze [France] ; Andreas Hartmann [France] ; Thomas Lescot [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France]Proliferation of microglial cells induced by 1-methyl-4-phenylpyridinium in mesencephalic cultures results from an astrocyte-dependent mechanism : role of granulocyte macrophage colony-stimulating factor
000B03 Sophie Mourlevat [France] ; Thomas Debeir [France] ; Juan E. Ferrario [France] ; Jean Delbe [France] ; Daniele Caruelle [France] ; Olivier Lejeune [France] ; Christel Depienne [France] ; José Courty [France] ; Rita Raisman-Vozari [France] ; Merle Ruberg [France]Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons : Analysis of suppression-subtracted cDNA libraries and confirmation in vitro
000B21 Carmen Henze [France] ; Thomas Lescot [France] ; Sabine Traver [France] ; Bénédicte Salthun-Lassalle [France] ; Etienne C. Hirsch [France] ; Patrick P. Michel [France] ; Andreas Hartmann [France]Granulocyte colony-stimulating factor is not protective against selective dopaminergic cell death in vitro
000B31 Thomas Debeir [France] ; Laure Ginestet [France] ; Chantal Francois [France] ; Stéphanie Laurens [France] ; Jean-Claude Martel [France] ; Philippe Chopin [France] ; Marc Marien [France] ; Francis Colpaert [France] ; Rita Raisman-Vozari [France]Effect of intrastriatal 6-OHDA lesion on dopaminergic innervation of the rat cortex and globus pallidus
000B64 Anne Marcilhac [France]Voies de signalisation intracellulaires, apoptose et pathologies neurodégénératives
000C15 Vincent Paille [France] ; Philippe Brachet [France] ; Philippe Damier [France]Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's disease
000C29 P. O. Fernagut [France] ; E. Diguet [France] ; B. Bioulac [France] ; F. Tison [France]MPTP potentiates 3-nitropropionic acid-induced striatal damage in mice: eeference to striatonigral degeneration
000D07 Olga Corti [France] ; Alexis Brice [France]La maladie de Parkinson : que nous apprennent les gènes responsables des formes familiales?
000D57 Jeffrey N. Joyce [États-Unis] ; Steve Presgraves [États-Unis] ; Lynn Renish [États-Unis] ; Sabinne Borwege [États-Unis] ; Tracy Osredkar [États-Unis] ; Diane Hagner [États-Unis] ; Maria Replogle [États-Unis] ; Mateo Pazsoldan [États-Unis] ; Mark J. Millan [France]Neuroprotective effects of the novel D3/D2 receptor agonist and antiparkinson agent, S32504, in vitro against 1-methyl-4-phenylpyridinium (MPP+) and in vivo against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a comparison to ropinirole
000D58 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
000E00 Günter U. Höglinger [France, Allemagne] ; Jean Feger [France] ; Annick Prigent [France] ; Patrick P. Michel [France] ; Karine Parain [France] ; Pierre Champy [France] ; Merle Ruberg [France] ; Wolfgang H. Oertel [Allemagne] ; Etienne C. Hirsch [France]Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats
000E38 Nathalie Lambeng [France] ; Raphaël Hourez [Belgique] ; Sakina Torch [France] ; Jean-Marc Verna [France] ; David Blum [Belgique]Mort neuronale dans les modèles expérimentaux de la maladie de Parkinson
000E87 Jean Dessolin [France] ; Marie Schuler [France] ; Alice Quinart [France] ; Francesca De Giorgi [France] ; Leon Ghosez [France] ; Francois Ichas [France]Selective targeting of synthetic antioxidants to mitochondria: towards a mitochondrial medicine for neurodegenerative diseases?
000E95 T. Breidert [France] ; J. Callebert [France] ; M. T. Heneka [Allemagne] ; G. Landreth [États-Unis] ; J. M. Launay [France] ; E. C. Hirsch [France]Protective action of the peroxisome proliferator-activated receptor-γ agonist pioglitazone in a mouse model of Parkinson's disease
000F14 Martine Barkats [France] ; Stéphanie Millecamps [France] ; Alicia Bilang-Bleuel [France] ; Jacques Mallet [France]Neuronal transfer of the human Cu/Zn superoxide dismutase gene increases the resistance of dopaminergic neurons to 6-hydroxydopamine
000F27 Baptiste A. Faucheux [France] ; Marie-Elise Martin [France] ; Carole Beaumont [France] ; Stéphane Hunot [France] ; Jean-Jacques Hauw [France] ; Yves Agid [France] ; Etienne C. Hirsch [France]Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease
000F41 Sophie Callier [France, Canada] ; Maryvonne Le Saux [France] ; Anne-Marie Lhiaubet [France] ; Thérèse Di Paolo [Canada] ; William Rostene [France] ; Didier Pelaprat [France]Evaluation of the protective effect of oestradiol against toxicity induced by 6-hydroxydopamine and 1-methyl-4-phenylpyridinium ion (MPP+) towards dopaminergic mesencephalic neurones in primary culture
000F44 Aïcha Douhou [France] ; Thomas Debeir [France] ; Mario Gustavo Murer [Argentine] ; Louis Do [France] ; Noëlle Dufour [France] ; Véronique Blanchard [France] ; Saliha Moussaoui [France] ; Georg Andrees Bohme [France] ; Yves Agid [France] ; Rita Raisman-Vozari [France]Effect of chronic treatment with riluzole on the nigrostriatal dopaminergic system in weaver mutant mice
001005 Roger G. Boulu [France] ; Christian Mesenge ; Christiane Charriaut-Marlangue ; Catherine Verrecchia ; Michel Plotkine ; Michel Bourel ; Roger Nordmann ; Claude Dreux ; Jacques-Louis Binet ; Gabriel BlancherMort neuronale : rôle potentiel d'une enzyme nucléaire, la poly(ADP-ribose) polymérase. Discussion
001067 Zdenko Herceg [France] ; Zhao-Qi Wang [France]Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death
001095 David Blum [Belgique, France] ; Sakina Torch [France] ; Marie-France Nissou [France] ; Jean-Marc Verna [France]6-hydroxydopamine-induced nuclear factor-kappab activation in PC12 cells
001129 M. Ruberg [France]Maladie de Parkinson: Vers un mécanisme de mort neuronale
001218 D. Blum [Belgique, France] ; S. Torch [France] ; M.-F. Nissou [France] ; A.-L. Benabid [France] ; J.-M. Verna [France]Extracellular toxicity of 6-hydroxydopamine on PC12 cells
001237 A. Nicotra [Italie] ; S. H. Parvez [France]Cell death induced by MPTP, a substrate for monoamine oxidase B
001241 Makoto Naoi [Japon] ; Wakako Maruyama [Japon] ; Yukihito Akao [Japon] ; JIN ZHANG [Japon] ; Hasan Parvez [France]Apoptosis induced by an endogenous neurotoxin, N-methyl(R)salsolinol, in dopamine neurons
001364 P. P. Michel [France] ; M. Marien [France] ; M. Ruberg [France] ; F. Colpaert [France] ; Yves Agid [France]Adenosine prevents the death of mesencephalic dopaminergic neurons by a mechanism that involves astrocytes
001368 E. Bezard [France] ; C. E. Gross [France] ; M.-C. Fournier [France] ; S. Dovero [France] ; B. Bloch [France] ; M. Jaber [France]Absence of MPTP-lnduced neuronal death in mice lacking the dopamine transporter
001378 Canaux K+ et neurodégénérescence : implication des canaux K+ sensibles à l'ATP et des canaux K+ régulés par les protéines G dans la dégénérescence neuronale
001436 M. Merad-Boudia [France] ; A. Nicole [France] ; D. Santiard-Baron [France] ; C. Saille [France] ; I. Ceballos-Picot [France]Mitochondrial impairment as an early event in th process of apoptosis induced by glutathione depletion in neuronal cells : Relevance to Parkinson's disease
001441 E. C. Hirsch [France] ; B. A. Faucheux [France]Iron metabolism and Parkinson's disease
001470 Toxicité du glutamate sur des cultures primaires de neurones mésencéphaliques de la substance noire
001508 P. Damier [France]Lésions neurochimiques et mécanismes de la mort neuronale dans la maladie de Parkinson : Maladie de Parkinson
001515 M. Ruberg [France] ; V. France-Lanord [France] ; B. Brugg [France] ; N. Lambeng [France] ; P. P. Michel [France] ; P. Anglade [France] ; S. Hunot [France] ; P. Damier [France] ; B. Faucheux [France] ; E. Hirsch [France] ; Yves Agid [France]La mort neuronale par apoptose dans la maladie de Parkinson
001558 E. Bezard [France] ; T. Boraud [France] ; B. Bioulac [France] ; C. E. Gross [France]Presymptomatic revelation of experimental Parkinsonism
001648 A. Mouatt-Prigent [France] ; J. O. Karlsson ; Yves Agid [France] ; E. C. Hirsch [France]Increased M-calpain expression in the mesencephalon of patients with Parkinson's disease but not in other neurodegenerative disorders involving the mesencephalon : A role in nerve cell death ?
001655 C. Adelbrecht [France] ; Yves Agid [France] ; R. Raisman-Vozari [France]Effect of the weaver mutation on the expression of dopamine membrane transporter, tyrosine hydroxylase and vesicular monoamine transporter in dopaminergic neurons of the substantia nigra and the ventral tegmental area
001658 P. Damier [France] ; A. Kastner [France] ; Yves Agid [France] ; E. C. Hirsch [France]Does monoamine oxidase type B play a role in dopaminergic nerve cell death in Parkinson's disease ?
001690 Yves Agid [France] ; L. Montagnier ; M. Bourel ; G. Serratrice ; R. Nordmann ; G. Blancher ; C. Pilet ; M.-O. Mme Rethore ; H. Lestradet ; J. Polonovski ; H. Bouissou ; P. Lefebvre ; J.-L. De GennesLe vieillissement, la maladie et la mort des cellules nerveuses. Discussion
001750 Enzymes de protection contre les radicaux libres dans le système nerveux central de l'homme ― avec une référence particulière pour le mécanisme de la mort des neurones dopaminergiques dans la maladie de Parkinson
001800 G. Boka [France] ; P. Anglade [France] ; D. Wallach ; F. Javoy-Agid [France] ; Yves Agid [France] ; E. C. Hirsch [France]Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease
001810 P. Hantraye [France] ; E. BrouilletChronic treatment with mitochondrial toxins in primates as experimental models of Parkinson's and Huntington's diseases
001819 Automatisation de la quantification histologique par analyse d'image. Application à l'étude du mécanisme de la mort neuronale dans la maladie de Parkinson
001830 Yves Agid [France]Mécanisme de la mort cellulaire dans les affections neurodégénératives : à propos de la maladie de Parkinson
001877 P. Damier [France] ; E. C. Hirsch ; P. Zhang ; Yves Agid [France] ; F. Javoy-AgidGlutathione peroxidase, glial cells and Parkinson's disease
001878 M.-T. Herrero [France] ; A. Kastner [France] ; I. Perez-Otano ; E. C. Hirsch [France] ; M.-R. Luquin ; F. Javoy-Agid [France] ; J. Del Rio ; J. A. Obeso ; Yves Agid [France]Gangliosides and parkinsonism
001943 E. C. Hirsche [France]Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease ?
001947 P. P. Michel [France] ; Yves Agid [France]The glutamate antagonist, MK-801, does not prevent dopaminergic cell death induced by the 1-methyl-4-phenylpyridinium ion (MPP+) in rat dissociated mesencephalic cultures
001954 A. Kastner [France] ; E. C. Hirsch ; O. Lejeune ; F. Javoy-Agid ; O. Rascol [France] ; Yves Agid [France]Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content ?

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024